Hong, David S <br/><br/>
Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Apr 2019 
 - 2403-2413 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-18-1341  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Humans<br/>Maximum Tolerated Dose<br/>Neoplasms<br/>Protein Kinase Inhibitors<br/>Pyridones<br/>Treatment Outcome<br/>Triazoles